ClinConnect ClinConnect Logo
Search / Trial NCT02800525

Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions Treatment

Launched by MAHIDOL UNIVERSITY · Jun 10, 2016

Trial Information

Current as of June 25, 2025

Unknown status

Keywords

Benign Pigmented Lesions Picosecond Laser Q Switched Laser

ClinConnect Summary

Benign pigmented lesions can be divided into epidermal lesions such as freckles, lentigines, solar lentigines or cafe au lait macules and dermal lesions such as Nevus of Ota or Hori's nevus.

Q-switched 532 and 1064 nm lasers were reported to be safe and effective in the treatment of these benign pigmented lesions. By using selective photothermolysis theory, both q-switched 532 and 1064 nm lasers target on melanin causes photomechanical destruction of the melanin. However, the occurrence of post inflammatory hyperpigmentation (PIH) were reported especially in patients with darker skin type....

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age \>18
  • having any benign pigmented lesions on both sides of the face or any tattoo on any part of body which would like to be removed
  • Fitzpatrick skin phototype 3-5
  • Exclusion Criteria:
  • Previously treated with any laser within 3 months before enrollment into the study
  • Patients with lesions with any clinical suspicion of being pre-cancerous or skin malignancies of any kind
  • Patients who have photosensitive dermatoses
  • Pregnancy and lactation woman
  • Patients with wound infections (herpes, other) on the day of treatment
  • Patients with moderate and severe inflammatory acne, Immunosuppressed patients, history of vitiligo
  • Patients with unrealistic concerns/expectations and inability to do the appropriate post-operative care

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok, , Thailand

Patients applied

0 patients applied

Trial Officials

Woraphong Manuskiatti, Prof., M.D.

Principal Investigator

Department of Dermatology, Siriraj Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials